Controlling Residual Host Cell Proteins (HCP) Impurities in Biopharmaceuticals Biotherapeutics must be free of Bioprocess-related impurities, including protein contaminants derived from the Host Cell used as the expression system (bacterium, yeast, mammalian, insect or plant cells). HCP fit the definition of the Critical Quality Attribute (CQA) due to their potential … Continue reading →

IDBiotech will attend the B4B conference “Innovation and Trends in Vaccine Industry” November 24th and 25th,  2015 – Toulouse – France     Do not hesitate to contact us if you want to meet us there !        

 CUSTOM IMMUNOASSAY and ELISA DEVELOPMENT according to your own specifications IDBiotech can develop and manufacture an Immunoassay (ELISA, Lateral Flow, SRID our Latex) according to your own specifications. We can also redesing and optimize an existing ELISA and deliver a ready-to-use test kit in your lab. We offer very flexible … Continue reading →